MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

MassDevice Earnings Roundup

Phase Forward pays a price for prosperity

By Leave a Comment

Phase Forward Inc. (NSDQ:PFWD)‎ paid a small price for success during the fourth quarter, as mounting expenses from a flurry of acquisitions swung it into the black.

The Waltham, Mass.-based clinical data management provider reported a net loss of $68,000 for the three months ended Dec. 30, 2009, compared to more than $2 million in net income for the same period in 2008. Full-year net income fell by 38 percent to $8 million, compared with nearly $14 million during Q4 2008.

Officials attributed the bottom-line drop to non-cash expenses including a $2.3 million impairment charge and a $700,000 increase in the amortization of intangible assets resulting from acquisitions.*

ConMed swings from red to black despite Q4 sales slide

By Leave a Comment

ConMed Corp. (NSDQ:CNMD) posted fourth-quarter sales of $179.2 million for the three months ended Dec. 31, 2009, down 6 percent compared with $190.6 million during the same period in 2008. Net income rose 67.9 percent to $8.3 million, compared with $5 million during Q4 2008:

Press Release

CONMED Corporation Announces Fourth Quarter and Full Year 2009 Results

Fourth Quarter Sales Increase 6.4%

Micrus Endovascular swings to black ink during Q3

By Leave a Comment

Micrus Endovascular Corp. (NSDQ:MEND) posted third-quarter sales of $22.8 million for the three months ended Dec. 31, 2009, up 24.4 percent compared with $18.3 million during the same period in 2008. The company swung from a net loss of $2.3 million during Q3 2009 to net income of $3.3 million during Q3 2010:

Press Release

Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20

Record Quarterly Revenues up 24%; Double-digit Revenue Growth in All Major Geographic Regions; Fourth Consecutive Quarter of Profitability

Bottom line surges 254 percent for Medical Action Industries

By Leave a Comment

Medical Action Industries Inc. (NSDQ:MDCI) posted third-quarter sales of $73.2 million for the three months ended Dec. 31, 2009, up 1.6 percent compared with $72 million during the same period in 2008. Net income surged 245 percent to $4 million, compared with $157,000 during Q3 2009:

Press Release

Medical Action Industries Reports Strong Third Quarter 2010 Fiscal Results

Company Reports Gains in Net Income and Gross Profit; Increase in Cash Flow Facilitates a $9.7 Million Debt Reduction in the Third Quarter and a $30.7 Million Debt Reduction Year to Date

Q3 Impella sales help Abiomed close in on the black

By Leave a Comment

Abiomed Inc. (NSDQ:ABMD) continued its ride toward profitability on the back of its Impella cardiac assist device, paring its third-quarter net loss by more than 40 percent and posting a 32 percent increase in total sales.

The Danvers, Mass.-based company reported net losses of $4.6 million, or 12 cents per share, on revenues of $22.8 million during the three months ended Dec. 31, 2009, compared with net losses of $7.7 million, or 21 cents per share, on revenues of $17.3 million during Q3 2009.

Thermo Fisher posts record Q4 sales

By Leave a Comment

Thermo Fisher Scientific Inc. (NYSE:TMO) posted record sales during the fourth quarter, but full-year sales suffered from the downturn in the capital expenditures market earlier in 2009.

The Waltham, Mass.-based lab instruments and services provider posted sales of $2.84 billion during the three months ended Dec. 31, 2009, up 7.3 percent compared with $2.65 billion during the same period in 2008. Net income slipped 4.8 percent to $273 million, or 65 cents per diluted share, compared with $287 million, or 67 cents per share, during Q4 2008.

Vascular Solutions posts Q4 sales gain, earnings plunge

By Leave a Comment

Vascular Solutions Inc. (NSDQ:VASC) posted fourth-quarter sales of $17.7 million for the three months ended Dec. 31, 2009, up 10.3 percent compared with $16.1 million during the same period in 2008. Net income fell 89 percent to $1.6 million, compared with $14.7 million during Q4 2008:

Millipore’s Q4, 2009 sales and earnings rise

By Leave a Comment

Millipore Corp.’s (NYSE:MIL) focus on selling consumables rather than big-ticket capital equipment paid off during the fourth quarter and full year 2009, as the Billerica, Mass.-based lab instruments maker posted strong sales and earnings numbers.

Fourth-quarter net income rose 41.2 percent to $43.9 million, or 78 cents per diluted share, compared with $31.1 million, or 56 cents per diluted share, during Q4 2008. Sale for the three months ended Dec. 31, 2009, rose 7.4 percent to $426 million, compared with $396.8 million during the same period last year, despite there being six fewer business days during Q4 2009.

Bottom line dips for ICU Medical despite Q4 sales boost

By Leave a Comment

ICU Medical Inc. (NSDQ:ICUI) posted fourth-quarter sales of $69.8 million for the three months ended Dec. 31, 2009, up 23 percent compared with $56.7 million during the same period last year. Net income fell 18 percent to $7.4 million, compared with $9 million during Q4 2008: